Comparison of the Clinico-Demographic Profile of Patients Admitted to the COVID ICU of a Tertiary Care Hospital in Assam During the First and Second Waves of the COVID-19 Pandemic

对阿萨姆邦一家三级医院在新冠疫情第一波和第二波期间入住新冠重症监护室患者的临床人口统计学特征进行比较

阅读:1

Abstract

BACKGROUND: With the passage of time, COVID-19 strains have mutated, leading to newer strains, and reports are there on the differences in presentation, severity, and infectivity of COVID-19 in the first two waves of the pandemic. OBJECTIVE: Comparison of the clinico-demographic profile and outcomes of patients admitted to the COVID ICU during the first and second waves. MATERIALS AND METHODS: A hospital-based cross-sectional study was conducted for a period of six months among patients admitted to the COVID ICU of Jorhat Medical College and Hospital, a tertiary care hospital in Assam, including 284 patients. Data were collected from bed head tickets available in the Medical Records Department office. The t-test and χ2 test were used to compare data between the two waves. RESULTS: In the first wave, most of the patients were 60 years and above, while in the second wave, the majority of cases were between 40 and 60 years (χ(2 )= 13.002, p = 0.011). The presenting symptoms and the type of co-morbidities were similar in both waves. Mean delay in testing and hospitalization was significantly more in the second wave (p = 0.005 and 0.02, respectively). Requirement of high flow O(2) therapy (p = 0.006) and ventilatory support (p = 0.03) was higher in the second wave. The treatment protocol remained the same in both waves, except for universal use of remdesivir and decreased plasma therapy use in the second wave. The mean duration of hospital stay was longer in the second wave (p = 0.02). There was a decrease in deaths from 42.1% to 36.1%, while discharges against medical advice increased from 2.1% to 12.5%. CONCLUSIONS: The data of the study gave us an insight into the changes and similarities of the two waves. Understanding the disease at the local level can help us be better prepared in case of any further recurrence of the pandemic.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。